Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer Inc. Declares Dividend for the Fourth Quarter 2021, Payable on December 6, 2021

09/23/2021 | 08:00am EDT

Pfizer Inc. announced that its board of directors declared a 39 cent fourth quarter 2021 dividend on the company’s common stock, payable December 6, 2021, to holders of the Common Stock of record at the close of business on November 5, 2021.


© S&P Capital IQ 2021
All news about PFIZER, INC.
10/26Swissmedic OKs Pfizer/BioNTech COVID-19 Booster Jabs For High Risk People
MT
10/26Pfizer, BioNTech Get US FDA Panel's Endorsement for COVID-19 Vaccine in Children 5 and ..
MT
10/26FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the P..
BU
10/26FDA Panel Recommends Authorization of Pfizer/BioNTech COVID-19 Vaccine for Kids Aged 5 ..
MT
10/26U.S. administers over 415 mln doses of COVID-19 vaccines - CDC
RE
10/26TRILLIUM THERAPEUTICS BRIEF : Securityholders Approve Acquisition by Pfizer
MT
10/26Trillium Securityholders Approve Acquisition by Pfizer
AQ
10/26Health Care Up Amid Drug Development Hopes -- Health Care Roundup
DJ
10/26PRESS RELEASE : FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorizat..
DJ
10/26PRESS RELEASE : FDA Advisory Committee Votes in -2-
DJ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 557 M - -
Net income 2021 18 627 M - -
Net Debt 2021 29 307 M - -
P/E ratio 2021 12,8x
Yield 2021 3,62%
Capitalization 244 B 244 B -
EV / Sales 2021 3,35x
EV / Sales 2022 3,82x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 43,56 $
Average target price 45,72 $
Spread / Average Target 4,96%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.17.22%244 227
JOHNSON & JOHNSON5.32%431 938
ROCHE HOLDING AG15.61%338 364
NOVO NORDISK A/S59.69%243 351
ELI LILLY AND COMPANY47.15%222 158
MERCK & CO., INC.-0.17%206 712